3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
57
Mesothelioma
35
Unspecified Adult Solid Tumor, Protocol Specific
25
Solid Tumor
9
Advanced Solid Tumors
8
Advanced Solid Tumor
7
Solitary Fibrous Tumor, Pleural
6
Carcinoma, Non-Small-Cell Lung
6
Sarcoma
4
Lung Neoplasms
4
Solid Tumors
3
Peritoneal Neoplasms
3
Neoplasms
3
Stomach Neoplasms
2
Retinoblastoma
2
Prostatic Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Extensive Stage Small Cell Lung Cancer
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Advanced Solid Tumour
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Interventions
belinostat
2
sodium thiosulfate
1
X-Rays
1
Specimen Handling
1
Quality of Life
1
Platinum
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fluorouracil
1
Drug Therapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Biological Therapy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Cisplatin
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled